Thermo Fisher Scientific to Support mRNA-based Vaccine Candidate Production for BioNTech

Thermo Fisher Scientific to Support mRNA-based Vaccine Candidate Production for BioNTech Agreement ensures consistent supply of nucleotides, enzymes and other critical raw materials for messenger RNA (mRNA) vaccine manufacturing platform WALTHAM, Mass., Feb. 26, 2019 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today announced it has signed a multi-year agreement with Mainz,... Read more

Thermo Fisher Scientific's Oncomine Dx Target Test Receives Expanded Regulatory Approval in Japan

Thermo Fisher Scientific’s Oncomine Dx Target Test Receives Expanded Regulatory Approval in Japan Companion diagnostic test enables physicians to identify non-small cell lung cancer patients who may benefit from eight targeted therapies CARLSBAD, Calif., Feb. 26, 2019 /PRNewswire/ — Thermo Fisher Scientific today announced that the Ministry of Health, Labour and Welfare (MHLW), Japan’s regulatory agency,... Read more

Thermo Fisher Scientific Launches New Dosimetry Monitoring Service

Medical and dental facilities, nuclear power plants and other sites can now simplify their radiation safety program by accessing dosimetry technology and services from single provider TEWKSBURY, Mass., Feb. 25, 2019 /PRNewswire/ — A new dosimetry monitoring service from Thermo Fisher Scientific enables medical and imaging facilities, dental offices, veterinary clinics, nuclear power plants, laboratories and... Read more

Thermo Fisher Scientific's Analytical Instruments Receive Industry Recognition with Prestigious Awards

Thermo Fisher Scientific’s Analytical Instruments Receive Industry Recognition with Prestigious Awards WALTHAM, Mass., Feb. 6, 2019 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today announced that several of its analytical instruments have received multiple prestigious industry awards. These award-winning tools provide scientists across a range of fields and disciplines with the... Read more

Thermo Fisher Scientific Signs Agreement to Sell its Anatomical Pathology Business

WALTHAM, Mass., Jan. 28, 2019 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that it has signed a definitive agreement to sell its Anatomical Pathology business to PHC Holdings Corporation, a global innovator in healthcare solutions, for approximately $1.14 billion in cash. The Anatomical Pathology business is a... Read more

Ultra-High-Power X-ray System Improves Inspection of Large, Dense Food Products and Packages

Ultra-High-Power X-ray System Improves Inspection of Large, Dense Food Products and Packages The Thermo Scientific Xpert Heavy Duty system delivers 900W of X-ray power for high penetration of large cases, bags and trays MINNEAPOLIS, Jan. 22, 2019 /PRNewswire/ — The latest X-ray inspection system from Thermo Fisher Scientific offers the highest X-ray power available, enabling... Read more

Thermo Fisher Scientific to Present at 37th Annual J.P. Morgan Healthcare Conference on January 8, 2019

Thermo Fisher Scientific to Present at 37th Annual J.P. Morgan Healthcare Conference on January 8, 2019 WALTHAM, Mass., Jan. 2, 2019 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, president and chief executive officer, will present at the 37th Annual J.P. Morgan Healthcare Conference on Tuesday,... Read more

Gatan Acquisition Requires Further UK Review

WALTHAM, Mass. and SARASOTA, Fla., Dec. 19, 2018 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and Roper Technologies, Inc. (NYSE: ROP), a leading diversified technology company, today announced that Thermo Fisher’s pending acquisition of Gatan, Inc., a wholly owned subsidiary of Roper, requires further review by the Competition and... Read more

Thermo Fisher Scientific Launches Complementary Diagnostic Immunoassay Measuring Plazomicin Concentrations

Thermo Fisher Scientific Launches Complementary Diagnostic Immunoassay Measuring Plazomicin Concentrations FREMONT, Calif., Dec. 10, 2018 /PRNewswire/ — Thermo Fisher Scientific has received FDA clearance for its de novo submission of the Thermo Scientific QMS Plazomicin Immunoassay, the first of its kind for complementary diagnostic immunoassays. This quantitative immunoassay measures the concentration of a novel therapeutic... Read more

Thermo Fisher Scientific Opens New Bioprocess Design Center in Shanghai

SHANGHAI, Nov. 30, 2018 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today opened its first Bioprocess Design Center in Shanghai, China. The new center is part of a strategy to establish a center of excellence where Thermo Fisher scientists can connect and collaborate with biologic developers to design optimal bioprocessing solutions.  The 2,700-square-meter... Read more